Covered recipient · General Payments record
SCOTT PODNOS
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$3,338.12
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $750.01 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.70 | 17 |
| GENZYME CORPORATION | $192.47 | 3 |
| Amgen Inc. | $76.20 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $52.94 | 2 |
| Janssen Biotech, Inc. | $41.66 | 2 |
| Kerecis Limited | $35.28 | 2 |
| Regeneron Healthcare Solutions, Inc. | $31.34 | 1 |
| ORGANOGENESIS INC. | $26.69 | 1 |
| Biofrontera Inc. | $24.41 | 1 |
| UCB, Inc. | $21.86 | 1 |
| Kyowa Kirin, Inc. | $21.74 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.23 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282802 | CMS |
| ABBVIE INC. | $11.72 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282806 | CMS |
| ABBVIE INC. | $17.19 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282810 | CMS |
| ABBVIE INC. | $27.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282814 | CMS |
| ABBVIE INC. | $5.20 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282818 | CMS |
| ABBVIE INC. | $3.45 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282822 | CMS |
| ABBVIE INC. | $3.71 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282826 | CMS |
| ABBVIE INC. | $3.40 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282830 | CMS |
| ABBVIE INC. | $23.53 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282834 | CMS |
| ABBVIE INC. | $15.78 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282838 | CMS |
| ABBVIE INC. | $4.02 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282842 | CMS |
| ABBVIE INC. | $4.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282846 | CMS |
| ABBVIE INC. | $5.03 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282850 | CMS |
| ABBVIE INC. | $16.73 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282854 | CMS |
| ABBVIE INC. | $8.16 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282858 | CMS |
| ABBVIE INC. | $24.30 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282862 | CMS |
| ABBVIE INC. | $7.99 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282866 | CMS |
| Amgen Inc. | $20.08 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657295 | CMS |
| Amgen Inc. | $28.18 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657297 | CMS |
| Amgen Inc. | $27.94 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117657299 | CMS |
| Biofrontera Inc. | $24.41 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093026121 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.72 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117853709 | CMS |
| GENZYME CORPORATION | $124.13 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139664220 | CMS |
| GENZYME CORPORATION | $33.04 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139664268 | CMS |
| GENZYME CORPORATION | $35.30 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139664272 | CMS |
| Janssen Biotech, Inc. | $25.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078519672 | CMS |
| Janssen Biotech, Inc. | $16.66 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078519476 | CMS |
| Kerecis Limited | $19.15 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120098876 | CMS |
| Kerecis Limited | $16.13 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120109427 | CMS |
| Kyowa Kirin, Inc. | $21.74 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127042793 | CMS |
| Novartis Pharmaceuticals Corporation | $22.21 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087318753 | CMS |
| Novartis Pharmaceuticals Corporation | $30.73 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087318799 | CMS |
| Organogenesis Inc. | $26.69 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145443161 | CMS |
| Regeneron Healthcare Solutions, Inc. | $31.34 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114138470 | CMS |
| UCB, Inc. | $21.86 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143028114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.